Tweet
Report: Dutrow-trained horse tests positive for Clenbuterol
NEW YORK -- A horse trained by Rick Dutrow tested positive for twice the allowable level of Clenbuterol, a bronchodilator that helps burn fat and promote muscle growth, The New York Times reported Wednesday.
The Kentucky Horse Racing Authority will issue the ruling Wednesday, suspend Dutrow for 15 days and demand the horse's owner to return the $20,000 in purse earnings, racing officials told the newspaper.
Dutrow has 10 days to appeal the penalty, which trainers often do to delay serving the suspension. The horse, Salute the Count, finished second in a $100,000 stakes race at Churchill Downs the day before Big Brown won the Kentucky Derby.
"I was there all week and am responsible," Dutrow told The Times. "I use that medication on many of my horses and only once can ever remember having a problem with it."
Clenbuterol is an approved medication in horses. The bronchodilator increases lung capacity, though it has steroidal properties. It is illegal to administer it on race day, but states vary on the length of time beforehand that it can be administered. In New York, for example, it cannot be administered within 96 hours of race day. In Kentucky, the length of time is 72 hours.
Dutrow has been fined or suspended at least once every year since 2000 for doping issues. In 2000, a barn search in New York produced "an injectible vitamin which is forbidden." In 2001, a horse had excessive Lasix -- an anti-bleeding medication -- in its system. In '02, Dutrow "failed to follow Lasix procedures." In '03, a horse tested positive for Mepivacaine. From '04 through an '08 fine in Florida, there were citations regarding Lasix, Clenbuterol, Phenylbutazone and Oxyphenbutazone.
The trainer served a 60-day suspension in 2005 after two of his horses tested positive for banned substances and for a claiming violation. Then, in 2007, he served an additional 14-day suspension and was fined $25,000 for violating conditions of his suspension by having contact with his stable.
Information from The Associated Press and ESPN.com senior writer Pat Forde was used in this report.
NEW YORK -- A horse trained by Rick Dutrow tested positive for twice the allowable level of Clenbuterol, a bronchodilator that helps burn fat and promote muscle growth, The New York Times reported Wednesday.
The Kentucky Horse Racing Authority will issue the ruling Wednesday, suspend Dutrow for 15 days and demand the horse's owner to return the $20,000 in purse earnings, racing officials told the newspaper.
Dutrow has 10 days to appeal the penalty, which trainers often do to delay serving the suspension. The horse, Salute the Count, finished second in a $100,000 stakes race at Churchill Downs the day before Big Brown won the Kentucky Derby.
"I was there all week and am responsible," Dutrow told The Times. "I use that medication on many of my horses and only once can ever remember having a problem with it."
Clenbuterol is an approved medication in horses. The bronchodilator increases lung capacity, though it has steroidal properties. It is illegal to administer it on race day, but states vary on the length of time beforehand that it can be administered. In New York, for example, it cannot be administered within 96 hours of race day. In Kentucky, the length of time is 72 hours.
Dutrow has been fined or suspended at least once every year since 2000 for doping issues. In 2000, a barn search in New York produced "an injectible vitamin which is forbidden." In 2001, a horse had excessive Lasix -- an anti-bleeding medication -- in its system. In '02, Dutrow "failed to follow Lasix procedures." In '03, a horse tested positive for Mepivacaine. From '04 through an '08 fine in Florida, there were citations regarding Lasix, Clenbuterol, Phenylbutazone and Oxyphenbutazone.
The trainer served a 60-day suspension in 2005 after two of his horses tested positive for banned substances and for a claiming violation. Then, in 2007, he served an additional 14-day suspension and was fined $25,000 for violating conditions of his suspension by having contact with his stable.
Information from The Associated Press and ESPN.com senior writer Pat Forde was used in this report.
Comment